Euromedis Laboratories: Successful OCA issuance

Laboratoires Euromedis has successfully completed its issue of convertible bonds (OCA) for a total amount of 2,999,880 euros. The operation, which took place from 18 to 29 November 2024 with preferential subscription rights (DPS), saw the issue of 624,975 OCA.

Nina stood out by subscribing to a large part of the issue, with 527,336 OCA for 2,531,212.80 euros, or 84.37% of the total. The issue was oversubscribed by 122.67%, with demand totaling 766,690 OCA.

This initiative aims to strengthen Euromedis' cash position to repay OCAs issued in 2019. At the end of the conversion, a potential dilution is expected, reducing the share of equity per share from €7.67 to €7.16.